A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world's population and is generally ...

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated tumors.

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.